Search - tctmd.com

Displaying 981 - 1000 of 3286

Sort: Relevancy | Date

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

News Daily News

Hearts, Lungs, Kidneys: Mild-to-Moderate COVID-19 Leaves a Mark

January 14, 2022

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

News Features

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

January 13, 2022

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

January 10, 2022

COVID-19: TCTMD’s Dispatch for January Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 2

January 10, 2022

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

January 07, 2022

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

News Daily News

CDC Extends COVID-19 Boosters to Adolescents, but Myocarditis Is Top of Mind

January 06, 2022

Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES

News Daily News

Heavy Calcification Levels PCI/CABG Playing Field at 10 Years: SYNTAXES

Yael L. Maxwell

January 06, 2022

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

News Daily News

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

Yael L. Maxwell

January 03, 2022

COVID-19: TCTMD’s Dispatch for January Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for January Week 1

January 03, 2022

Progress Against Acute MI Deaths in Nonelderly US Adults Has Plateaued

News Daily News

Progress Against Acute MI Deaths in Nonelderly US Adults Has Plateaued

December 30, 2021

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

News Daily News

AHA’s 2021 Top Picks: Headway Continues to Be Made Against CVD

December 28, 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

COVID-19: TCTMD’s Dispatch for December Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 4

December 27, 2021

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

Women Less Likely Than Men to Experience SCD During Sports

News Daily News

Women Less Likely Than Men to Experience SCD During Sports

Michael O'Riordan

December 21, 2021

FDA Approves Two Additional Indications for Rivaroxaban in Children

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

December 21, 2021

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

News Daily News

PASCAL Pinpoints Patients With Strokes Causally Related to PFO

Yael L. Maxwell

December 20, 2021

For Angina Patients, Language Barriers Can Complicate CVD Care

News Daily News

For Angina Patients, Language Barriers Can Complicate CVD Care

December 20, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.